Healthcare

Image

Global Clinical Chemistry Analyzer Market – Industry Trends and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • Mar 2024
  • Global
  • 350 Pages
  • No of Tables: 50
  • No of Figures: 250

Global Clinical Chemistry Analyzer Market – Industry Trends and Forecast to 2031

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2023–2031
Diagram Market Size (Base Year) USD 14.15 Billion
Diagram Market Size (Forecast Year) USD 20.59 Billion
Diagram CAGR %

Global Clinical Chemistry Analyzer Market, Product (Analyzers, Reagents, Calibtators, Controls, Standards, and Others) Analyzer Technology (Semi-Automated Clinical Chemistry Analyzers and Fully Automated Clinical Chemistry Analyzers), Test Analysis (Basic Metabolic Panel (BMP), Liver Panel, Electrolyte Panel, Renal Profile, Lipid Profile, Specialty Chemical Tests, and Thyroid Function Panel) End User Analysis (Hospitals, Academic Research Centers, Diagnostic Laboratories, and Others) – Industry Trends and Forecast to 2031.

Clinical Chemistry Analyzer Market Analysis and Size

The global clinical chemistry analyzer market thrives on its ability to accurately measure substance concentrations in serum samples, aiding medical diagnoses and treatment. For instance, assessing serum cholesterol levels helps diagnose cardiovascular diseases, and guide treatment decisions. These analyzers provide crucial data to healthcare professionals, enhancing patient care and disease management worldwide, which drives market growth.

Data Bridge Market Research analyses that the global clinical chemistry analyzer market was growing at a value of USD 14.15 billion in 2023 and is expected to reach a value of USD 20.59 billion in 2031 and register a CAGR of 4.8% from 2024 to 2031. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, patent analysis and consumer behavior.  

Report Scope and Market Segmentation      

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product (Analyzers, Reagents, Calibtators, Controls, Standards, and Others) Analyzer Technology (Semi-Automated Clinical Chemistry Analyzers and Fully Automated Clinical Chemistry Analyzers), Test Analysis (Basic Metabolic Panel (BMP), Liver Panel, Electrolyte Panel, Renal Profile, Lipid Profile, Specialty Chemical Tests, and Thyroid Function Panel) End User Analysis (Hospitals, Academic Research Centers, Diagnostic Laboratories, and Others)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America

Market Players Covered

Abbott (U.S.), Danaher (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Siemens (Germany), ELI Tech Group (France), HORIBA, Ltd.( Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Randox Laboratories Ltd. (U.K.), Ortho Clinical Diagnostics (U.S.), Nova Biomedical (U.S.), Sysmex Corporation (Japan), Bio Systems Diagnostics Pvt. Ltd. (India), DiaSys Diagnostic Systems GmbH (Germany), Endress+Hauser Group Services AG (Switzerland), Diatron (Hungary), SFRI SAS (France), EKF and Medica Corporation (U.K.)

Market Opportunities

  • Adoption of Portable and Compact Analyzers
  • Surge in Demand for Personalized Medicine

Market Definition

A clinical chemistry analyzer is a medical device used to measure chemicals in body fluids such as blood and urine. It helps doctors understand patients' health by analyzing substances such as glucose, cholesterol, and electrolytes. This information aids in diagnosing diseases such as diabetes and monitoring organ functions for better treatment decisions.

Global Clinical Chemistry Analyzer Market Dynamics

Drivers

  • Rising Demand for Diagnostic Testing Services  / Growing Prevalence of Chronic Diseases and Aging Poplulation Increase Demand for Diagnostic Testing Services  

As healthcare awareness increases globally, there is a heightened focus on early disease detection and prevention. Clinical chemistry analyzers play a pivotal role in providing accurate and timely diagnostic information, aiding healthcare professionals in making informed decisions for patient care. With the growing prevalence of chronic diseases and the aging population, the demand for clinical chemistry analyzers continues to rise, driving market expansion and innovation. Thus, the rising demand for diagnostic testing services acts as a significant driver in the market growth.

  • Growing Investments in Healthcare Enhanced Diagnostic Capabilities

Increased investments enable healthcare facilities to upgrade their diagnostic capabilities, including acquiring advanced clinical chemistry analyzers. This expansion of infrastructure enhances accessibility to diagnostic services, especially in underserved regions. Moreover, modern healthcare facilities prioritize accurate and efficient diagnostic procedures, leading to a higher demand for clinical chemistry analyzers. Consequently, the market experiences growth as healthcare systems worldwide try to improve patient care through enhanced diagnostic capabilities. Thus, the growing investments in healthcare infrastructure contribute to market growth.

Opportunities

  • Adoption of Portable and Compact Analyzers/Enabling Point-of-Care Testing in Various Healthcare Sector 

Portable analyzers offer flexibility and convenience, enabling point-of-care testing in various healthcare settings such as clinics, remote areas, and ambulances. They facilitate rapid diagnosis and treatment decisions, leading to improved patient outcomes and reduced healthcare costs. In aaddition, compact analyzers require less space and resources, making them suitable for small laboratories and resource-limited settings. Thus, their adoption drives market growth by enhancing accessibility and efficiency in diagnostic testing which drives the demand for clinical chemistry analyzer and further drives the market growth.

  • Surge in Demand for Personalized Medicine in Assessing Biomarkers

Personalized medicine tailors treatments to individual patients based on genetic, environmental, and lifestyle factors. Clinical chemistry analyzers play a crucial role in assessing biomarkers and monitoring patients' responses to personalized therapies. As the healthcare industry shifts towards precision medicine, there is a heightened need for accurate and comprehensive diagnostic tools, driving the demand for advanced clinical chemistry analyzers capable of supporting personalized treatment approaches.

Restraints/Challenges

  • Compatibility Issues with Existing Healthcare Infrastructure

Integrating new analyzers into established healthcare systems can be challenging due to differences in technology standards and data management protocols. Legacy systems may lack compatibility with modern analyzer interfaces, hindering seamless operation and data exchange. This issue not only increases implementation costs but also disrupts workflow efficiency, potentially impacting patient care. Hence, the compatibility issues with existing healthcare infrastructure pose a significant restraint in the clinical chemistry analyzer market growth.

  • Lack of Skilled Personnel for Analyzer Operation

The analyzers demand intricate understanding and technical proficiency to ensure accurate testing and interpretation of results. Skilled personnel are essential to troubleshooting issues, calibrating instruments, and maintaining quality control standards, critical for patient diagnosis and treatment decisions. Without adequately trained operators, the risk of errors increases, potentially compromising patient care and clinical outcomes. Moreover, the specialized nature of operating these analyzers requires investment in training programs, further exacerbating the challenge amid the ongoing shortage of qualified personnel in healthcare settings. Hence, the  shortage of skilled personnel for operating is restraining the market growth.

This global clinical chemistry analyzer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global clinical chemistry analyzer market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

  • In July 2023, Beckman Coulter Diagnostics received FDA clearance for the DxC 500 AU Chemistry Analyzer, an automated system designed for small-to-medium-sized laboratories. The analyzer, featuring standardized assays, enhances clinical decision-making and patient outcomes with proven Six Sigma performance, supporting efficiency and reliability in diagnostic testing devices and boosting the market growth
  • In March 2023, Thermo Fisher Scientific acquired Binding Site Group for 2.3 billion (USD 2.8 billion). The addition of The Binding Site expands Thermo Fisher's Specialty Diagnostics segment, particularly in oncology testing for multiple myeloma. This acquisition enhances the company's capabilities to meet growing demand for specialized diagnostics, fueling innovation and advancing healthcare solutions in the oncology sector
  • In May 2023, Siemens Healthineers introduced the Atellica HEMA 570 and 580 Analyzers for high-volume hematology testing. These solutions feature intuitive interfaces, multi-analyzer automation connectivity, and rules-based testing to streamline workflows and provide fast and reliable results for physicians and patients which is fostering market growth
  • In May 2022, Mindray launched the BS-600M, a powerful, efficient chemistry analyzer that is designed to empower medium-volume laboratories with increased productivity, efficiency, and reliability
  • In April 2022, Sysmex Europe launched its new three-part differential system, the XQ-320 XQ-Series Automated Hematology Analyzer. With reliable technology and a new level of usability, the XQ-320 brings excellence in quality to a diverse range of clinical laboratory environments

Global Clinical Chemistry Analyzer Market Scope

The global clinical chemistry analyzer market is segmented into four notable segments based on product, analyzer technology, test analysis, and end user analysis. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Analyzers
  • Reagents
  • Calibtators
  • Controls
  • Standards
  • Others

Analyzer Technology

  • Semi-Automated Clinical Chemistry Analyzers
  • Fully Automated Clinical Chemistry Analyzers

Test Analysis

  • Basic Metabolic Panel (BMP
  • Liver Panel
  • Electrolyte Panel
  • Renal Profile
  • Lipid Profile
  • Specialty Chemical Tests
  • Thyroid Function Panel

End User Analysis

  • Hospitals
  • Academic Research Centers
  • Diagnostic Laboratories
  • Others

Global Clinical Chemistry Analyzer Market Regional Analysis/Insights

The global clinical chemistry analyzer market is analysed and market size insights and trends are provided by based on product type,  application type,  distribution channel, and end user analysis as referenced above.

The countries covered in the global clinical chemistry analyzer market report are U.S., canada, mexico, germany, italy, u.k., france, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, rest of Europe, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.

North America dominates the global clinical chemistry analyzer market due to the encouraging initiatives taken by the government and the increased application of practice guidelines released by healthcare organizations will further boost the growth of the clinical chemistry analyzer market in the region during the forecast period.

Asia-Pacific is projected to observe a significant amount of growth in the global clinical chemistry analyzer market due to the increase in research and development investment by the global players. Moreover, the occurrence of unmapped opportunities is further anticipated to propel the growth of the clinical chemistry analyzer market in the region in the coming years.

The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global clinical chemistry analyzer market also provides you with a detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global clinical chemistry analyzer market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global clinical chemistry analyzer market . The data is available for the historic period 2016-2021.

Competitive Landscape and Global Clinical Chemistry Analyzer Market Share Analysis

The global clinical chemistry analyzer market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related toglobal clinical chemistry analyzer market .

Some of the major players operating in the global clinical chemistry analyzer market are:

  • Abbott (U.S.)
  • Danaher (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Siemens (Germany)
  • ELI Tech Group (France)
  • HORIBA, Ltd.( Japan)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
  • Randox Laboratories Ltd. (U.K.)
  • Ortho Clinical Diagnostics (U.S.)
  • Nova Biomedical (U.S.)
  • Sysmex Corporation (Japan)
  • Bio Systems Diagnostics Pvt. Ltd. (India)
  • DiaSys Diagnostic Systems GmbH (Germany)
  • Endress+Hauser Group Services AG (Switzerland)
  • Diatron (Hungary)
  • SFRI SAS (France)
  • EKF and Medica Corporation (U.K.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The increasing prevalence of chronic diseases, ongoing technological advancements & growing aging population are the growth drivers of the clinical chemistry analyzer market.
The Product, analyzer technology, test analysis, and end-user analysis are the factors on which the clinical chemistry analyzer market research is based.
The Major companies in the clinical chemistry analyzer market are Abbott (U.S.), Danaher (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Siemens (Germany), ELI Tech Group (France), HORIBA, Ltd.( Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Randox Laboratories Ltd. (U.K.), Ortho Clinical Diagnostics (U.S.), Nova Biomedical (U.S.), Sysmex Corporation (Japan), Bio Systems Diagnostics Pvt. Ltd. (India), DiaSys Diagnostic Systems GmbH (Germany), Endress Hauser Management AG (Switzerland), Diatron (Hungary), SFRI. (France), EKF and Medica Corporation (U.K.).
The Clinical Chemistry Analyzer Market size will be worth USD 20.59 billion in 2031 during the forecast period.
The Clinical Chemistry Analyzer Market growth rate is CAGR of 4.8% during the forecast period.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials